Organon, a US-based pharmaceutical firm, launched Nuvaring, a birth control vaginal ring, in India on Wednesday. The firm claims that this will make contraceptive process simpler for women and the contraceptive has no side effects.

Nuvaring is a flexible, transparent ring made up of inert plastics. The ring consists of hormones that enter the bloodstream directly, thus slowing down ovulation.

"Nuvaring makes the contraception procedure simpler for women. Instead of taking a pill every day, the ring needs to be inserted once every week. Three weeks of insertion followed by one week ring-free interval is the procedure that needs to be repeated every month for a continued contraceptive effect," said Urvashi Jha, Director of the Institute of Obstetrics and Gynaecology, Max Healthcare.

K.G. Ananthakrishnan, Managing Director of Organon (India), said, "Around 20 percent women use contraceptives in India. The ring will be good as does not have any side effects and will not cause obstruction in any other routine activity."